Braun Stacey Associates’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Braun Stacey Associates’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-299,156	Closed	-$9.97M	–	121
2024 Q3	$9.97M	Buy	+299,156	New	+$10.3M	0.38%	82

Braun Stacey Associates's LBPH Position: Q4 2024 in Review

Braun Stacey Associates sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 299,156 shares — an estimated $9.97M sold.

Braun Stacey Associates first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $9.97M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Braun Stacey Associates reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Braun Stacey Associates sold 299,156 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $9.97M.
Braun Stacey Associates first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Braun Stacey Associates's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $9.97M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Braun Stacey Associates's 13F filing for Q4 2024, filed 31 Jan 2025.